ReviewFrontiers in immunology2023

Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors.

Julien Ancel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.